Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.500
+0.130 (9.49%)
At close: Mar 9, 2026, 4:00 PM EDT
1.500
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:20 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $93.40 million as of March 9, 2026. Its market cap has increased by 15.48% in one year.
Market Cap
93.40M
Enterprise Value
31.85M
1-Year Change
15.48%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $93.40M, a decrease of -82.17%. That is a compound annual growth rate of -32.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 85.30M | 19.13% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 90.92M |
| MAIA Biotechnology | 90.34M |
| iBio, Inc. | 90.16M |
| Kazia Therapeutics | 89.89M |
| PMV Pharmaceuticals | 87.27M |
| OKYO Pharma | 85.27M |
| Verrica Pharmaceuticals | 84.91M |
| Seres Therapeutics | 82.59M |